Ultrasensitive radioimmunoassay of prostate-specific antigen.
We describe a modification of the Yang Pros-check radioimmunoassay for prostate-specific antigen (PSA) that increases the analytical sensitivity of the assay approximately threefold (from a working range of 0.3-50 to 0.1-1.2 micrograms/L). It can detect PSA added to zero-concentration diluent (bovine serum albumin solution) at 0.10 microgram/L or added to zero-concentration control female serum at 0.20 microgram/L (P less than 0.05). In 26 patients tested after cystoprostatectomy for bladder cancer (who had normal prostates without cancer on histologic examination), PSA values by this ultrasensitive assay were all less than 0.10 microgram/L. Therefore, we propose this value as the upper limit of the 95% reference interval. In a retrospective study of two patients who developed recurrent prostate cancer, serum PSA values increased above the 0.1 microgram/L detection limit 175 and 581 days before increasing above the 0.3 microgram/L detection limit of the standard Yang assay. This ultrasensitive radioimmunoassay of PSA should prove more useful than current methods for detecting early recurrence of prostate cancer.
Graves
H C
HC
Department of Urology, Stanford University Medical Center, CA 94305-5118.
Wehner
N
N
Stamey
T A
TA
D000951:Antigens, Neoplasm / Q000097:blood*; D002138:Calibration; D015653:Cystectomy; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000276:immunology; D017430:Prostate-Specific Antigen; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000276:immunology / Q000601:surgery; D011786:Quality Control; D011863:Radioimmunoassay / Q000379:methods* / Q000592:standards / Q000706:statistics & numerical data; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000601:surgery
D000951:Antigens, Neoplasm; D017430:Prostate-Specific Antigen